跳转至内容
Merck
CN
  • Surgical management of placenta accreta: to leave or remove the placenta?

Surgical management of placenta accreta: to leave or remove the placenta?

BJOG : an international journal of obstetrics and gynaecology (2014-01-01)
A Perez-Delboy, J D Wright
摘要

Abnromalities of placentation, including placenta accreta, represent a major source of morbidity and mortality among women. Traditional management consists of peripartum hysterectomy at the time of delivery, although more conservative treatments have also been developed recently. In this review we describe the available literature describing the operative approach and considerations for management of women with placenta accreta.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
甲氨蝶呤 水合物, ≥98% (HPLC), powder
Sigma-Aldrich
甲氨蝶呤 水合物, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
Sigma-Aldrich
甲氨蝶呤, meets USP testing specifications
Supelco
甲氨蝶呤,1 X 100MG 溶液, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
甲氨蝶呤, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
甲氨蝶呤 水合物, ≥99.0% (sum of enantiomers, HPLC)
甲氨蝶呤, European Pharmacopoeia (EP) Reference Standard